Related Experiment Video
Updated: Sep 9, 2025

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.1K
Penicillin Allergy Delabeling in Pediatric Primary Care: A Multisite Qualitative Study
Eileen J Carter1, Elizabeth Monsees2, Sharon Hwang3
1University of Connecticut (EJ Carter), School of Nursing, Storrs, Conn.
Academic Pediatrics
|August 30, 2025
Summary
Primary care practitioners see benefits in penicillin allergy delabeling for children. Key barriers include training, time, and resources, with recommendations for improved protocols and caregiver engagement to facilitate delabeling.
Area of Science:
- Pediatric Allergy and Immunology
- Primary Care Medicine
- Health Services Research
Background:
- Penicillin allergy (PA) delabeling is recommended for low-risk children, with growing evidence for its safety in pediatric primary care settings.
- Primary care practitioners' perspectives are crucial for understanding and implementing PA delabeling initiatives.
- This study explores primary care practitioners' attitudes, perceived barriers, and enablers for PA delabeling.
Purpose of the Study:
- To identify primary care practitioners' attitudes towards penicillin allergy delabeling in children.
- To explore perceived barriers and enablers to implementing PA delabeling in primary care settings.
- To inform the development of interventions supporting PA delabeling in pediatric primary care.
Main Methods:
- Semi-structured interviews and focus groups were conducted with 29 primary care practitioners across two health systems.
- Content analysis was used to code interview and focus group transcripts.
- Barriers and enablers were mapped to the Capability, Opportunity, and Motivation (COM-B) model.
Main Results:
- Practitioners recognized the benefits of PA delabeling for children and reported previous attempts at delabeling.
- Identified barriers included lack of skills/training (capability), caregiver resistance, and inadequate time/staff/space (opportunity).
- Motivation to delabel was mixed, influenced by perceived barriers.
Conclusions:
- Primary care practitioners view PA delabeling as beneficial for pediatric health.
- Interventions should focus on enhancing practitioner skills, securing caregiver engagement, and optimizing resources (time, space).
- Collaboration with allergists for delabeling protocols is recommended to facilitate implementation in primary care.
More Related Videos
Related Concept Videos
Allergic Reactions
28.5K
Overview
28.5K
Allergic Drug Reactions
972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983

